Fexofenadine and famotidine lack clinical trial evidence for menopausal symptoms
1. The viral combination of fexofenadine and famotidine for menopausal symptoms is built on a plausible histamine hypothesis but has ...
Tag: vasomotor symptoms
#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Bayer AG: Elinzanetant Shows Promise In Treating Menopause-Associated Vasomotor Symptoms In Phase 3 Clinical Trials
Elinzanetant reduced the frequency and severity of menopause-associated vasomotor symptoms in two phase 3 clinical trials. Elinzanetant was safe and ...
Severe premenstrual disorder may increase risk of early onset perimenopausal symptoms
1. This prospective study found that women with severe premenstrual disorders (PMDs) were at increased risk for early onset of ...
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...
Paroxetine a good non-hormonal option for hot flashes
1. Paroxetine use was associated with decreased frequency of hot flashes and lower composite vasomotor symptom (VMS) severity score. 2. ...
